Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings
Sandra Bonache(CIBBIM-Nanomedicine), I. Esteban(Universitat Autònoma de Barcelona), Alejandro Moles‐Fernández(CIBBIM-Nanomedicine), Anna Tenés(Vall d'Hebron Hospital Universitari), Laura Duran-Lozano(CIBBIM-Nanomedicine), Gemma Montalban(CIBBIM-Nanomedicine), Vanessa Bach(CIBBIM-Nanomedicine), Estela Carrasco(Spanish Ovarian Cancer Research Group), Neus Gadea(Vall d'Hebron Hospital Universitari), Adrià López‐Fernández(Spanish Ovarian Cancer Research Group), Sara Torres‐Esquius(Spanish Ovarian Cancer Research Group), Francesco M. Mancuso(CIBBIM-Nanomedicine), Ginevra Caratù(CIBBIM-Nanomedicine), Ana Vivancos(CIBBIM-Nanomedicine), Noemí Tuset(Hospital Universitari Arnau de Vilanova), Judith Balmañà(Vall d'Hebron Hospital Universitari), Sara Gutiérrez‐Enríquez(Vall d'Hebron Institut de Recerca), Orland Dı́ez(Hebron University)
Cited by 65Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis